13 results
SC 14D9/A
EX-99
TXMD
TherapeuticsMD Inc
13 Jul 22
Tender offer solicitation (amended)
7:53am
and operations and potential difficulties in employee retention as a result of the failure of the proposed transaction; risks related to diverting management’s
SC14D9C
TXMD
TherapeuticsMD Inc
31 May 22
Written communication relating to third party tender offer
7:55am
results, and business generally; (5) risks that the proposed transaction disrupts current plans and operations and potential difficulties in employee … retention as a result of the proposed transaction; (6) risks related to diverting management’s attention from ongoing business operations; (7
SC TO-T/A
EX-99
Athene Merger Sub, Inc.
23 Jun 22
Third party tender offer statement (amended)
4:07pm
disrupts current plans and operations and potential difficulties in employee retention as a result of the proposed transaction; (6) risks related
8-K
EX-99.2
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
difficulties in employee retention as a result of the proposed transaction; (6) risks related to diverting management’s attention from ongoing business
SC TO-C
TXMD
TherapeuticsMD Inc
31 May 22
Information about tender offer
10:02am
, and business generally; (5) risks that the proposed transaction disrupts current plans and operations and potential difficulties in employee retention
8-K
EX-99.1
rcgenc78jsm97
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
SC TO-T
EX-99
cnsbh
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-99.1
yi4r9yl10tkhwerp9
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
SC TO-C
EX-99.1
gl6s5d7weem3c f8
31 May 22
Information about tender offer
10:02am
SC14D9C
EX-99.1
kp93e
31 May 22
Written communication relating to third party tender offer
7:55am
8-K
8ruqk3g1r
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
- Prev
- 1
- Next